In August 2018, the FDA warned that sodium-glucosecotransporter-2 (SLGT2) inhibitors such as Invokana can cause a rare but serious infection that could cause an amputation of the genital area.
This is a big deal because Invokana is a commonly used diabetes medication. The list of diabetes drugs that have let patients down is long. The money in these drugs is unreal. To make the most money, you need to rush your product on the market without fully testing the drug. That is the biggest problem.
Long before the FDA got involved, I have been looking at potential Invokana lawsuits. These are the 11 questions victims have about Invokana and the Invokana litigation.












